The Brain Tumor Segmentation (BraTS) Challenge 2023: Local Synthesis of Healthy Brain Tissue via Inpainting
Authors:
Florian Kofler,
Felix Meissen,
Felix Steinbauer,
Robert Graf,
Eva Oswald,
Ezequiel de da Rosa,
Hongwei Bran Li,
Ujjwal Baid,
Florian Hoelzl,
Oezguen Turgut,
Izabela Horvath,
Diana Waldmannstetter,
Christina Bukas,
Maruf Adewole,
Syed Muhammad Anwar,
Anastasia Janas,
Anahita Fathi Kazerooni,
Dominic LaBella,
Ahmed W Moawad,
Keyvan Farahani,
James Eddy,
Timothy Bergquist,
Verena Chung,
Russell Takeshi Shinohara,
Farouk Dako
, et al. (43 additional authors not shown)
Abstract:
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with a scan that is already pathological. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantees for images featuring lesions. Examples include…
▽ More
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with a scan that is already pathological. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantees for images featuring lesions. Examples include but are not limited to algorithms for brain anatomy parcellation, tissue segmentation, and brain extraction. To solve this dilemma, we introduce the BraTS 2023 inpainting challenge. Here, the participants' task is to explore inpainting techniques to synthesize healthy brain scans from lesioned ones. The following manuscript contains the task formulation, dataset, and submission procedure. Later it will be updated to summarize the findings of the challenge. The challenge is organized as part of the BraTS 2023 challenge hosted at the MICCAI 2023 conference in Vancouver, Canada.
△ Less
Submitted 9 August, 2023; v1 submitted 15 May, 2023;
originally announced May 2023.
